SG11201810725WA - Novel β-lactamase inhibitors - Google Patents
Novel β-lactamase inhibitorsInfo
- Publication number
- SG11201810725WA SG11201810725WA SG11201810725WA SG11201810725WA SG11201810725WA SG 11201810725W A SG11201810725W A SG 11201810725WA SG 11201810725W A SG11201810725W A SG 11201810725WA SG 11201810725W A SG11201810725W A SG 11201810725WA SG 11201810725W A SG11201810725W A SG 11201810725WA
- Authority
- SG
- Singapore
- Prior art keywords
- lactamase inhibitors
- novel
- disclosed
- lactamase
- novelb
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610394846 | 2016-06-03 | ||
| PCT/CN2017/086999 WO2017206947A1 (zh) | 2016-06-03 | 2017-06-02 | 新型β-内酰胺酶抑制剂 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201810725WA true SG11201810725WA (en) | 2018-12-28 |
Family
ID=60477996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201810725WA SG11201810725WA (en) | 2016-06-03 | 2017-06-02 | Novel β-lactamase inhibitors |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10738051B2 (de) |
| EP (1) | EP3466950B1 (de) |
| JP (1) | JP6929881B2 (de) |
| KR (1) | KR102392350B1 (de) |
| CN (1) | CN109311881B (de) |
| AU (1) | AU2017274131B2 (de) |
| CA (1) | CA3026322C (de) |
| ES (1) | ES2863725T3 (de) |
| MY (1) | MY193239A (de) |
| RU (1) | RU2741963C2 (de) |
| SG (1) | SG11201810725WA (de) |
| WO (1) | WO2017206947A1 (de) |
| ZA (1) | ZA201808552B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2928152T3 (es) * | 2017-12-01 | 2022-11-15 | Qilu Pharmaceutical Co Ltd | Forma cristalina de un inhibidor de beta-lactamasa y método de preparación de la misma |
| CN111511737B (zh) * | 2018-01-29 | 2022-10-18 | 南京明德新药研发有限公司 | 用于治疗细菌感染的单环β-内酰胺化合物 |
| EP3978506A4 (de) * | 2019-05-30 | 2022-08-31 | Zhuohe Pharmaceutical Group Co., Ltd | Antibakterielle aminoglykosidderivate |
| WO2021121387A1 (zh) * | 2019-12-19 | 2021-06-24 | 南京明德新药研发有限公司 | 化合物在制药中的应用 |
| CN113292499B (zh) * | 2020-02-24 | 2024-05-28 | 齐鲁制药有限公司 | 一种β-内酰胺酶抑制剂的新制备方法及其中间体 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100463403C (zh) * | 2006-03-20 | 2009-02-18 | 腾讯科技（深圳）有限公司 | 一种基于点对点技术的图片共享系统和方法 |
| JP4809097B2 (ja) * | 2006-03-29 | 2011-11-02 | ルネサスエレクトロニクス株式会社 | 受信回路及び受信方法 |
| CN103649051B (zh) | 2011-06-17 | 2016-04-13 | 阿斯利康(瑞典)有限公司 | 制备包括反-7-氧代-6-(磺基氧基)-1,6-二氮杂二环[3,2,1]辛烷-2-甲酰胺的杂环化合物及其盐的方法 |
| US9505761B2 (en) * | 2011-12-02 | 2016-11-29 | Fedora Pharmaceuticals Inc. | Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors |
| US8796257B2 (en) | 2011-12-02 | 2014-08-05 | Naeja Pharmaceutical Inc. | Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors |
| TW201343646A (zh) * | 2012-03-30 | 2013-11-01 | Cubist Pharm Inc | 異□唑β－內醯胺酶抑制劑 |
| SG10201605368UA (en) | 2012-05-30 | 2016-08-30 | Meiji Seika Pharma Co Ltd | NOVEL β-LACTAMASE INHIBITOR AND PROCESS FOR PREPARING THE SAME |
| US20150203503A1 (en) | 2012-08-25 | 2015-07-23 | Wockhardt Limited | 1,6- diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections |
| UA111925C2 (uk) * | 2012-12-11 | 2016-06-24 | Федора Фармасьютікалз Інк. | БІЦИКЛІЧНІ СПОЛУКИ ТА ЇХ ВИКОРИСТАННЯ ЯК АНТИБАКТЕРІАЛЬНИХ АГЕНТІВ ТА ІНГІБІТОРІВ β-ЛАКТАМАЗИ |
-
2017
- 2017-06-02 CN CN201780034023.6A patent/CN109311881B/zh active Active
- 2017-06-02 JP JP2018562934A patent/JP6929881B2/ja active Active
- 2017-06-02 RU RU2018146128A patent/RU2741963C2/ru active
- 2017-06-02 US US16/305,414 patent/US10738051B2/en active Active
- 2017-06-02 ES ES17805892T patent/ES2863725T3/es active Active
- 2017-06-02 EP EP17805892.1A patent/EP3466950B1/de active Active
- 2017-06-02 CA CA3026322A patent/CA3026322C/en active Active
- 2017-06-02 SG SG11201810725WA patent/SG11201810725WA/en unknown
- 2017-06-02 MY MYPI2018002269A patent/MY193239A/en unknown
- 2017-06-02 AU AU2017274131A patent/AU2017274131B2/en active Active
- 2017-06-02 WO PCT/CN2017/086999 patent/WO2017206947A1/zh unknown
- 2017-06-02 KR KR1020187037429A patent/KR102392350B1/ko active IP Right Grant
-
2018
- 2018-12-19 ZA ZA2018/08552A patent/ZA201808552B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20190015350A (ko) | 2019-02-13 |
| EP3466950B1 (de) | 2021-02-24 |
| RU2018146128A3 (de) | 2020-07-10 |
| JP6929881B2 (ja) | 2021-09-01 |
| US10738051B2 (en) | 2020-08-11 |
| CN109311881B (zh) | 2021-07-13 |
| WO2017206947A1 (zh) | 2017-12-07 |
| ES2863725T3 (es) | 2021-10-11 |
| CA3026322C (en) | 2023-08-15 |
| EP3466950A4 (de) | 2019-11-20 |
| CN109311881A (zh) | 2019-02-05 |
| ZA201808552B (en) | 2022-11-30 |
| EP3466950A1 (de) | 2019-04-10 |
| MY193239A (en) | 2022-09-27 |
| CA3026322A1 (en) | 2017-12-07 |
| KR102392350B1 (ko) | 2022-04-29 |
| RU2741963C2 (ru) | 2021-02-01 |
| US20200010467A1 (en) | 2020-01-09 |
| AU2017274131A1 (en) | 2019-01-24 |
| AU2017274131B2 (en) | 2020-10-08 |
| JP2019517501A (ja) | 2019-06-24 |
| RU2018146128A (ru) | 2020-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201810725WA (en) | Novel β-lactamase inhibitors | |
| MX2018010192A (es) | Inhibidores de glucosidasa. | |
| GEP20207105B (en) | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors | |
| MX2022006783A (es) | Nuevos derivados de metilquinazolinona. | |
| PH12015502031B1 (en) | Tetrahydropyrrolothiazine compounds | |
| MX2018010191A (es) | Inhibidores de glucosidasa. | |
| MY196186A (en) | Amino-Fluoropiperidine Derivatitves as Kinase Inhibitor | |
| CR20200116A (es) | Compuestos de bisamida que activan el sarcómero y sus usos | |
| SA520412335B1 (ar) | مشتقات أوكسي فلورو ببريدين كمثبط كيناز | |
| MX2020009234A (es) | Compuestos de heteroarilo como inhibidores de cinasas asociadas con receptores de interleucina-1 (irak) tipo ii y usos de los mismos. | |
| MX2020006613A (es) | Derivados de aril-bipiridina amina como inhibidores de fosfatidilinositol fosfato cinasa. | |
| AU2018253590A1 (en) | Imidazopyridazine compounds | |
| ZA202213152B (en) | Novel acid secretion inhibitor and use thereof | |
| PH12019500839A1 (en) | Therapeutic compounds and methods of use thereof | |
| MX2015017156A (es) | Inhibidores de bace. | |
| PH12019500875A1 (en) | Pyridone compound as c-met inhibitor | |
| MX2017005422A (es) | Inhibidores de histona desacetilasa y sus usos en terapia. | |
| MX2021015514A (es) | Compuesto heterociclico. | |
| MX2019006768A (es) | Peptidos antimicrobianos. | |
| TN2021000025A1 (en) | Novel heterocyclic amine derivative and pharmaceutical composition comprising same | |
| MX2018008966A (es) | Procesos mejorados para la preparacion de osimertinib (azd9291) o una sal del mismo y "azd9291 anilina" o una sal del mismo. | |
| SG11201907945YA (en) | Azetidine derivative | |
| MX2021009261A (es) | Compuesto de fluorovinilbenzamida como inmunomodulador pd-l1. | |
| TN2019000038A1 (en) | Triazolopyrazinone derivative useful as a human pde1 inhibitor | |
| PH12019502046A1 (en) | Pyrrolotriazine derivatives as kinase inhibitor |